Raptor Pharmaceutical | Evaluate

September 20, 2016

Allergan sparks a second liver disease craze

September 14, 2016

Vitae buyout marks another comedown for exuberant biotech bulls

September 12, 2016

Raptor faces up to its new reality

August 03, 2016

Therapy focus – One step forward but two steps back in Huntington’s

April 15, 2016

Upcoming events – Phase II data for Raptor and The Medicines Company

August 13, 2015

Upcoming events: Intra-Cellular and Raptor target unmet CNS needs

August 12, 2014

Intercept soars again as safety fears fade

March 17, 2014

Raptor picks a bad week to bury bad news

February 21, 2014

Glimmers of hope in Huntington's must not be overstated

June 20, 2013

Upcoming events: Alnylam and Biogen readouts plus decision time at the CHMP meeting

May 01, 2013

After Procysbi approval the pricing battle begins

Load More